已收录 268921 条政策
 政策提纲
  • 暂无提纲
Polymeric chloroquine as an inhibitor of cancer cell migration and experimental lung metastasis
[摘要] Chloroquine (CQ) is a widely used antimalarial drug with emerging potential in anticancer therapies due to its apparent inhibitory effects on CXCR4 chemokine receptor, autophagy, and cholesterol metabolism. This study reports on polymeric CQ (pCQ) as amacromolecular drug with antimetastatic activity. The pCQpolymers were synthesized by copolymerization of methacryloylated hydroxy-CQ (HCQ) and N-(2-hydroxypropyl) methacrylamide (HPMA). The results show that pCQ is significantly more effective in inhibiting cancer cell migration and invasion when compared with the parent HCQ. The proposed mechanism of action at least partially relies on the ability of pCQ to inhibit cell migration mediated by the CXCR4/CXCL12 pathway. The pCQ also demonstrates superior inhibitory activity over HCQ when tested in a mouse model of experimental lung metastasis. Lastly, pCQ shows the ability to efficiently translocate to the cytoplasm while exhibiting lower cytotoxicity than HCQ. Overall, this study supports pCQ as a promising polymeric drug platform suitable for use in combination antimetastatic strategies and potential use in cytoplasmic drug delivery. (C) 2016 Elsevier B.V. All rights reserved.
[发布日期] 2016-12-28 [发布机构] 
[效力级别]  Proceedings Paper [学科分类] 
[关键词] Polymeric drug;Metastasis;Chloroquine;HPMA;CXCR4;Endosomal release [时效性] 
   浏览次数:4      统一登录查看全文      激活码登录查看全文